Systemic Inflammatory Markers and Oncologic Outcomes in Patients With High-Risk Non–muscle-Invasive Urothelial Bladder Cancer

European urology oncology - Netherlands
doi 10.1016/j.euo.2018.06.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mp04-17 Blood-Based Biomarkers as Predictors of Oncologic Outcomes for Non-Muscle-Invasive Urothelial Bladder Carcinoma

Journal of Urology
Urology
2017English

Assessment of Recurrence and Progression Risk in Patients With Non-Muscle Invasive Bladder Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

RRM1 Predicts Clinical Outcome of High-And Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated With Intravesical Gemcitabine Monotherapy

BMC Urology
MedicineReproductive MedicineUrology
2019English

Preoperative Neutrophil–lymphocyte Ratio and Fibrinogen Level in Patients Distinguish Between Muscle-Invasive Bladder Cancer and Non-Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Long-Term Outcomes From Re-Resection for High-Risk Non–muscle-Invasive Bladder Cancer: A Potential to Rationalize Use

European Urology Focus
Urology
2019English

Prediction Tools in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Histological Variants in Non-Muscle Invasive Bladder Cancer

Translational Andrology and Urology
Reproductive MedicineUrology
2019English

Dietary Patterns and Risk of Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy